SeQure Dx (Series A)

Funding Details
Awarder
Inbox
Date Award
August 03, 2021
Vertical
Genomics
Funding URL
View Funding Page
Funding Amount:
$17,500,000

Company Info
Founders
Ellen Sheets, MD, MBA
Company Description
SeQure Dx provides safety data for on and off-target CRISPR gene editing therapies
Market
Gene Therapy
Location
Waltham, MA, USA
Coinvestors
Alexandria Venture Investments, Bold Capital, Casdin Capital, Digitalis Ventures, KdT Ventures, Mass General Brigham Ventures, RiverVest Venture Partners

Links